Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against...
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and...
The main purpose of this study is to evaulate the efficacy and safety of galcanezumab in participants 6 to 17...
English (USA)